Update in the diagnosis and management of transthyretin familial amyloid polyneuropathy (Q34422510)

2 August 2017

title

Update in the diagnosis and management of transthyretin familial amyloid polyneuropathy (English)

1 reference

Violaine Planté-Bordeneuve

2 August 2017

author

series ordinal

1

object named as

Violaine Plante-Bordeneuve

0 references

author name string

Violaine Plante-Bordeneuve

series ordinal

1

1 reference

2 August 2017

language of work or name

1 reference

3 June 2014

1 reference

2 August 2017

1 reference

2 August 2017

volume

261

1 reference

2 August 2017

issue

6

1 reference

2 August 2017

page(s)

1227-1233

1 reference

A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S00415-014-7373-0

Familial amyloid polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-014-7373-0

Guideline of transthyretin-related hereditary amyloidosis for clinicians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-014-7373-0

The molecular biology and clinical features of amyloid neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-014-7373-0

Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-014-7373-0

Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-014-7373-0

Neurophysiological markers of small fibre neuropathy in TTR-FAP mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-014-7373-0

Neurophysiological techniques to detect early small-fiber dysfunction in transthyretin amyloid polyneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-014-7373-0

Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-014-7373-0

The significance of carpal tunnel syndrome in transthyretin Val30Met familial amyloid polyneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-014-7373-0

21 January 2018

Amyloid heart disease

1 reference

https://api.crossref.org/works/10.1007/S00415-014-7373-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-014-7373-0

Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-014-7373-0

Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-014-7373-0

Overcoming artefact: anticipation in 284 Portuguese kindreds with familial amyloid polyneuropathy (FAP) ATTRV30M.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-014-7373-0

Liver transplantation and transthyretin amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-014-7373-0

Long-term data from the Familial Amyloidotic Polyneuropathy World Transplant Registry (FAPWTR)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-014-7373-0

Long-term survival after liver transplantation in patients with familial amyloid polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-014-7373-0

Variation in amount of wild-type transthyretin in different fibril and tissue types in ATTR amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-014-7373-0

Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-014-7373-0

Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-014-7373-0

Safety and efficacy of RNAi therapy for transthyretin amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-014-7373-0

4 ′‐iodo‐4′‐Deoxydoxorubicin and tetracyclines disrupt transthyretin amyloid fibrils in vitro producing noncytotoxic species: screening for TTR fibril disrupters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-014-7373-0

Doxycycline plus tauroursodeoxycholic acid for transthyretin amyloidosis: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-014-7373-0

Antibodies to human serum amyloid P component eliminate visceral amyloid deposits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-014-7373-0

The Transthyretin Amyloidosis Outcomes Survey (THAOS) registry: design and methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-014-7373-0

Clinical development of an antisense therapy for the treatment of transthyretin-associated polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-014-7373-0

Clinical and pathological findings of non-Val30Met TTR type familial amyloid polyneuropathy in Japan

21 January 2018

1 reference

12 December 2020

Familial amyloid polyneuropathy: mechanisms leading to nerve degeneration

1 reference

12 December 2020

Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP)

1 reference

12 December 2020

Acquired amyloid neuropathy in a Portuguese patient after domino liver transplantation

1 reference

12 December 2020

10.1007/S00415-014-7373-0

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

1015254823

0 references

1 reference